Other names: Humira
Categories: Prescription Medication
Description:
Adalimumab (brand name Humira) is a biologic DMARD that targets tumor necrosis factor-alpha (TNF-α), a key driver of inflammation in rheumatoid arthritis. It is given as a subcutaneous injection, usually every other week, and is often prescribed when patients have moderate to severe RA that does not respond well to methotrexate or other conventional DMARDs. Adalimumab can significantly reduce joint pain, swelling, and long-term damage, while improving function and quality of life. Common side effects include injection-site reactions and increased risk of infections (like tuberculosis or shingles), so patients require screening and ongoing monitoring. Despite its high cost, it is one of the most widely used biologics because of its strong track record of efficacy.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment "Adalimumab" against the disease "Rheumatoid Arthritis". Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment from the given data. More user feedback and clinical studies would be necessary to assess the efficacy of Adalimumab in treating Rheumatoid Arthritis.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
